Home >> Respiratory Devices >> Education >> Food & Beverage >>

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2014

Published: Dec-2014 | Format: PDF | GlobalData | Number of pages: 64 | Code: MRS - 3165

Summary

GlobalData's clinical trial report, “Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2014" provides data on the Bronchiolitis Obliterans clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchiolitis Obliterans. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bronchiolitis Obliterans. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bronchiolitis Obliterans 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Bronchiolitis Obliterans 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Bronchiolitis Obliterans Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
PARI GmbH 28
Clinical Trial Overview of PARI GmbH 28
APT Pharmaceuticals, Inc. (Inactive) 29
Clinical Trial Overview of APT Pharmaceuticals, Inc. (Inactive) 29
Clinical Trial Overview of Top Institutes / Government 30
Assistance Publique - Hopitaux de Paris 30
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 30
Universitaire Ziekenhuizen Leuven 31
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 31
National Heart, Lung, and Blood Institute 32
Clinical Trial Overview of National Heart, Lung, and Blood Institute 32
Fred Hutchinson Cancer Research Center 33
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 33
Baqiyatallah Medical Sciences University 34
Clinical Trial Overview of Baqiyatallah Medical Sciences University 34
Azienda Ospedaliera Universitaria San Martino 35
Clinical Trial Overview of Azienda Ospedaliera Universitaria San Martino 35
University of Michigan Comprehensive Cancer Center 36
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 36
University Health Network 37
Clinical Trial Overview of University Health Network 37
Rabin Medical Center 38
Clinical Trial Overview of Rabin Medical Center 38
Rigshospitalet 39
Clinical Trial Overview of Rigshospitalet 39
Five Key Clinical Profiles 40
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables

Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bronchiolitis Obliterans Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Bronchiolitis Obliterans Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bronchiolitis Obliterans Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bronchiolitis Obliterans Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Bronchiolitis Obliterans Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Bronchiolitis Obliterans Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Bronchiolitis Obliterans Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Bronchiolitis Obliterans Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by PARI GmbH, 2014* 28
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by APT Pharmaceuticals, Inc. (Inactive), 2014* 29
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 30
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 31
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 32
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 33
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2014* 34
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria San Martino, 2014* 35
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2014* 36
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 37
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2014* 38
Bronchiolitis Obliterans Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 39

List of Figures

Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bronchiolitis Obliterans Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Bronchiolitis Obliterans Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bronchiolitis Obliterans Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Bronchiolitis Obliterans Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Bronchiolitis Obliterans Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Bronchiolitis Obliterans to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Bronchiolitis Obliterans Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Bronchiolitis Obliterans Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Bronchiolitis Obliterans Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing